Sinopharm Group Co. Ltd. (HKG:1099)
17.08
-0.13 (-0.76%)
Jun 8, 2026, 4:09 PM HKT
Sinopharm Group Market Cap
Sinopharm Group has a market cap or net worth of 53.3 billion as of June 8, 2026. Its market cap has decreased by -7.27% in one year.
Market Cap
53.30B
Enterprise Value
156.01B
Revenue
652.76B
Ranking
n/a
PE Ratio
6.62
Stock Price
17.08
Market Cap Chart
Since September 23, 2009, Sinopharm Group's market cap has increased from 40.42B to 53.30B, an increase of 31.85%. That is a compound annual growth rate of 1.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 53.71B | -11.47% |
| Dec 31, 2025 | 60.67B | -8.73% |
| Dec 31, 2024 | 66.47B | 4.16% |
| Dec 29, 2023 | 63.82B | 3.07% |
| Dec 30, 2022 | 61.91B | 16.98% |
| Dec 31, 2021 | 52.93B | -10.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 160 Health International | 4.83B |
| ETHK Labs | 1.14B |
| Sipai Health Technology | 880.85M |
| China Health Group | 693.57M |
| Charmacy Pharmaceutical | 590.76M |
| ClouDr Group | 374.52M |
| Sinco Pharmaceuticals Holdings | 337.46M |
| Wanjia Group Holdings | 202.02M |